Sign Up | Already a member? Sign In
Pharma IQ

Missed a Pharma Conference? Watch Online Any Time!

Informative sessions on drug discovery, clinical development, logistics, manufacturing and more now available on demand through the B2B IQ store. Missed the conference? There is no need to miss out!

Interact With Your Community

Under the Networking and Q&A tabs, you can share tips, best practices, solutions and more -- leverage these tools to connect with your peers today!

Logistics for Clinical Trials in Emerging Markets

Mark Walls, Director of Clinical Pharmacy at Human Genome Sciences, talks about the need for pharmaceutical and biotech companies to optimise logistics and overcome inefficiencies in the clinical supply chain.


Presented By: Mark Walls

Drug Discovery and the Market Today: Video Exclusive with Dr. David Elder, GSK

Dr. David Elder, the Externalization Director for GlaxoSmithKline, talks exclusively to Pharma IQ on his perspective across the industry, including CROs, regulations, and strategising for efficiency.


Presented By: Dr. David Elder

Best Practice Tips for Overcoming Obstacles in Biomarker Development

How can we overcome the latest challenges in Biomarker Development? Birgitte Søgaard, Divisional Director for Clinical Pharmacology and Translational Medicine at H Lundbeck A/S, discusses the key challenges in this area.


Presented By: Birgitte Søgaard

High Risk: How Corrupt is Life Sciences?

According to Transparency International's Bribe Payers Index, among 19 industry sectors globally, life sciences is perceived to be the 6th most corrupt sector, in terms of the propensity of companies to pay bribes.


Presented By: Chandrashekhar Krishnan
Featured Content
Contributor: Pharma IQ
Posted: 9/1/2010


What Would You Do in the Case of a Virus Breakout in Your Manufacturing Plant? - Pharma IQ

The porcine circovirus contamination of GSK’s Rotarix vaccine in March of this year, and previous contaminations in both Baxter and Genzyme biological products in 2009, have highlighted the issue of viral safety in biologics more than ever before. In a recent interview Dr. Mark Plavsic, Senior Director, Gene Therapy Development Genzyme, spoke with Andrea Charles from Pharma IQ,... Full Article

 

Boosting Bioavailability Through Partnerships

Contributor: Pharma IQ
Posted: 9/3/2010


Boosting Bioavailability Through Partnerships - Pharma IQ

If the trends that have been seen in the pharmaceutical industry over the past few years prove anything, it is that drug development companies are increasingly recognising the value of teamwork. There is plenty of evidence that businesses in the sector are seeing the benefits that partners... Full Article

The Human Factor’s Engineering Process in the Development of Medical Device Software

Contributor: Edmond Israelski
Posted: 8/27/2010


The Human Factor’s Engineering Process in the Development of Medical Device Software

View this presentation to find out about integrating human factors engineering into medical devices to make them safe, effective and efficient to use, and the regulations for the human factors engineering process. Presented by Dr. Edmond W. Israelski, Hum... Full Article

Assessing the Impact of Single-Use Biomanufacturing Systems

Contributor: Pharma IQ
Posted: 9/3/2010


Assessing the Impact of Single-Use Biomanufacturing Systems

Whilst single-use systems have brought many advantages for bioprocessing, such as accelerated downtime and reduced costs, there are still some challenges that need to be addressed. Dr. Kit Erlebach, Head of Technical Commercial Manufacturing at Avecia, and Tony Hitchcoc... Full Article

The Dynamic Market: The Most Important Market Segment for Your Brand

Posted: 9/3/2010

The Dynamic Market: The Most Important Market Segment for Your Brand

The following interviews are part of a Five-Part Series on Marketing Excellence, which draws on landmark IMS research on more than 3,000 new product launches and analysis of 50 in-line brands spanning 10 chronic retail markets. Each offers insights from an IMS expert on best practices... Full Article


Advertisement

What documents are required for ANDA submission and how does the process work? Are the any good online guides?

Posted by:  Sumit Dutta | Answer this question

hi i was asking do i need a wrirten permision from you to write about your site or the news in your sit but i guide people to your site to register in the...

Posted by:  eman desouky | Answer this question

Is there a group on this site for people involved with SNP/Genetic research?

Posted by:  almour | Answer this question

What documents are required for ANDA submission and how does the process work?

Posted By:  Sumit Dutta | Answer this question

Advertisement


Andrea Charles

Andrea Charles
Content Editor

 
About Pharma IQ

Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical and biotechnology professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical and biotech community.

Through Pharma IQ, you will be able to access pharmaceutical information resources such as presentations and podcasts, as well as events such as webinars, seminars and conferences.

By signing up to the Pharma IQ membership, you will gain access to our growing database of multimedia presentations from leading pharma and biotech practitioners, weekly newsletters to keep you updated on latest pharmaceutical content and Pharma IQ members-exclusive discounts on pharma events that offer solutions to your everyday business problems.

Pharma IQ and IQPC provide useful training courses, conference and expositions for pharmaceutical and biotech executives to network and learn the latest pharma business development and trends occurring in organizations today. Pharma IQ focuses on establishing an interactive experience featuring practical, objective and up-to-date insight from pharma and biotech industry leaders.